These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8174492

  • 1. Immunopharmacological evaluation of bucillamine in rheumatoid arthritis.
    Matsuno H, Kitano T, Matsushita I, Tsuji H, Ochiai H.
    Drugs Exp Clin Res; 1993; 19(5):205-11. PubMed ID: 8174492
    [Abstract] [Full Text] [Related]

  • 2. [Bucillamine-induced dermatomyositis-like clinical features in a patient with rheumatoid arthritis].
    Takeda T, Shimizu Y, Takeuchi M, Hashimoto S, Nagai C, Uchiyama S, Iwata M.
    Rinsho Shinkeigaku; 2005 Jan; 45(1):45-8. PubMed ID: 15715001
    [Abstract] [Full Text] [Related]

  • 3. IgA rheumatoid factor correlates with changes in B and T lymphocyte subsets and disease manifestations in rheumatoid arthritis.
    Arinbjarnarson S, Jonsson T, Steinsson K, Sigfusson A, Jonsson H, Geirsson A, Thorsteinsson J, Valdimarsson H.
    J Rheumatol; 1997 Feb; 24(2):269-74. PubMed ID: 9034982
    [Abstract] [Full Text] [Related]

  • 4. Bucillamine suppresses human Th1 cell development by a hydrogen peroxide-independent mechanism.
    Morinobu A, Wang Z, Kumagai S.
    J Rheumatol; 2000 Apr; 27(4):851-8. PubMed ID: 10782806
    [Abstract] [Full Text] [Related]

  • 5. Administration of an anti-CD5 immunoconjugate to patients with rheumatoid arthritis: effect on peripheral blood mononuclear cells and in vitro immune function.
    Fishwild DM, Strand V.
    J Rheumatol; 1994 Apr; 21(4):596-604. PubMed ID: 7518519
    [Abstract] [Full Text] [Related]

  • 6. [A case of rheumatoid arthritis developing pemphigus-like skin lesion during treatment with bucillamine].
    Amasaki Y, Sagawa A, Atsumi T, Jodo S, Nakabayashi T, Watanabe I, Mukai M, Fujisaku A, Nakagawa S, Kobayashi H.
    Ryumachi; 1991 Oct; 31(5):528-34; discussion 531-3. PubMed ID: 1837388
    [Abstract] [Full Text] [Related]

  • 7. [A case of rheumatoid arthritis associated with agranulocytosis during bucillamine treatment].
    Negishi M, Yamazaki J, Hosaka M, Iwabuchi H, Matsuda A, Kanemitsu H, Hiramatsu K, Kaga S, Hashimoto M, Kasama T.
    Ryumachi; 1994 Jun; 34(3):651-5. PubMed ID: 8052932
    [Abstract] [Full Text] [Related]

  • 8. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.
    Yudoh K, Matsuno H, Nakazawa F, Yonezawa T, Kimura T.
    Arthritis Rheum; 2000 Mar; 43(3):617-27. PubMed ID: 10728756
    [Abstract] [Full Text] [Related]

  • 9. [A case of bucillamine-induced interstitial pneumonia].
    Hara A, Sakamoto O, Matsumoto M, Sakata T, Kohrogi H, Sugimoto M, Ando M, Araki S, Iwakiri T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1743-8. PubMed ID: 1447852
    [Abstract] [Full Text] [Related]

  • 10. [Bucillamine-associated membranous nephropathy in a patient with rheumatoid arthritis].
    Kawano M, Nomura H, Iwainaka Y, Nakashima A, Koni I, Tofuku Y, Takeda R.
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):817-21. PubMed ID: 2273598
    [Abstract] [Full Text] [Related]

  • 11. [Lung injury associated with bucillamine therapy].
    Negishi M, Kaga S, Kasama T, Hashimoto M, Fukushima T, Yamagata N, Tabata M, Kobayashi K, Ide H, Takahashi T.
    Ryumachi; 1992 Apr; 32(2):135-9. PubMed ID: 1595005
    [Abstract] [Full Text] [Related]

  • 12. [A case of pulmonary infiltration with eosinophilia (PIE) syndrome induced by bucillamine treatment of rheumatoid arthritis].
    Kishimoto N, Fujii K.
    Nihon Kokyuki Gakkai Zasshi; 2002 Apr; 40(4):321-5. PubMed ID: 12096503
    [Abstract] [Full Text] [Related]

  • 13. The immunoregulation of rheumatoid factor by the CD8 T lymphocyte subset in rheumatoid arthritis.
    al-Azem I, Fernandez-Madrid F, Long PM, Wooley PH.
    J Rheumatol; 1992 Sep; 19(9):1337-41. PubMed ID: 1279167
    [Abstract] [Full Text] [Related]

  • 14. Comparison of clinical effects of bucillamine between additive combination and single administration study in rheumatoid arthritis.
    Nobunaga M, Yasuda M.
    Agents Actions Suppl; 1993 Sep; 44():105-9. PubMed ID: 8372720
    [Abstract] [Full Text] [Related]

  • 15. Increased HLA-DR and CD44 antigen expression in the gut: evidence of extraarticular immunological activity in rheumatoid arthritis.
    Abuzakouk M, Feighery C, Kelleher D, O'Briain DS, Jones E, Weir D, Casey E, O'Farrelly C.
    J Rheumatol; 1999 Sep; 26(9):1869-76. PubMed ID: 10493664
    [Abstract] [Full Text] [Related]

  • 16. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B, Akça D, Jung T, Muller GA, Reuss-Borst MA.
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [Abstract] [Full Text] [Related]

  • 17. [A case of drug-induced interstitial pneumonitis in rheumatoid arthritis treated with bucillamine].
    Matsushima H, Takayanagi N, Sakamoto T, Motegi M, Ubukata M, Yanagisawa T, Sugita Y, Kanazawa M, Kawabata Y.
    Nihon Kokyuki Gakkai Zasshi; 2001 Jan; 39(1):55-9. PubMed ID: 11296388
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine.
    Okazaki H, Sato H, Kamimura T, Hirata D, Iwamoto M, Yoshio T, Mimori A, Masuyama JI, Kano S, Minota S.
    J Rheumatol; 2000 Jun; 27(6):1358-64. PubMed ID: 10852254
    [Abstract] [Full Text] [Related]

  • 19. [Clinicopathological evaluation and treatment of bucillamine induced membranous nephropathy].
    Kikuchi M, Saeki T, Ito S, In H, Saito T, Ueno M, Sato T, Suzuki S, Nakano M, Ozawa T.
    Ryumachi; 1993 Jun; 33(3):215-22. PubMed ID: 8346463
    [Abstract] [Full Text] [Related]

  • 20. Treatment with monoclonal anti-tumor necrosis factor alpha antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis.
    Maurice MM, van der Graaff WL, Leow A, Breedveld FC, van Lier RA, Verweij CL.
    Arthritis Rheum; 1999 Oct; 42(10):2166-73. PubMed ID: 10524689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.